Parenteral anticoagulation during hospitalization Class I recommendation
Early invasive strategy reduces recurrent ischemia in high-risk NSTEMI
GRACE-guided selection improves net benefit
High-intensity statin stabilizes plaque and reduces recurrent events
Early initiation Class I recommendation
Oxygen avoidance when not hypoxemic
Hyperoxia vasoconstriction and increased oxidative stress concern
Patient Discharge Instructions
copy discharge instructions
NSTEMI discharge instructions
Medications
Take aspirin exactly as prescribed
Take P2Y12 inhibitor exactly as prescribed
Do not stop antiplatelets without cardiology advice
Activity
Gradual return to activity per cardiac rehab plan
Avoid heavy exertion until cleared
Follow-up
Cardiology follow-up within 7 days or as directed
Cardiac rehabilitation enrollment
Risk reduction
No tobacco or vaping
Heart-healthy diet
Diabetes and blood pressure control plan
Return immediately to ED for
Chest pain at rest
Chest pain lasting more than 10 minutes
Shortness of breath at rest
Syncope or near-syncope
New weakness, trouble speaking, or facial droop
Black stools or vomiting blood
Severe headache or new neurologic symptoms while on blood thinners
References
Clinical guidelines and evidence sources
Core guideline sources
ACC/AHA guideline for management of patients with acute coronary syndromes
Class I recommendations for aspirin and anticoagulation in NSTEMI
Risk-guided early invasive strategy recommendations
ESC guidelines for non-ST-elevation acute coronary syndromes
GRACE-guided invasive strategy timing
Antithrombotic therapy recommendations
Emergency medicine chest pain pathways
ACEP clinical policy for evaluation and management of adult patients with suspected acute non-ST-elevation ACS
Use of validated accelerated diagnostic pathways
Shared decision-making for low-risk discharge
Landmark trial and registry concepts
DAPT trials supporting P2Y12 inhibitor use after ACS
Ticagrelor and prasugrel efficacy versus clopidogrel in ACS populations
Anticoagulation trials in UA/NSTEMI
UFH and LMWH outcome and bleeding tradeoffs
Risk score validation studies
HEART score outcomes for low-risk chest pain
GRACE risk prediction for mortality in ACS
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.